510(k) Report

510(k) · Cleared

Recalled · Class II · 2026

Citric Complete Liquid Citric Acid Concentrate

K223431510(k) TraditionalCleared Aug 4, 2023263-day reviewClass II21 CFR 876.5820Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nipro Renal Solutions USA, Corp. · KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

Cleared on Aug 4, 2023 as substantially equivalent to K160847 (Rockwell Medical, 2016) and 3 other predicates after a 263-day review. Its family tree reaches back 4 generations to 1987. 1 later device descends from it. It has been recalled once.

Decided
Aug 4, 2023
Review
263 days
Class
Class II
Product code
KPO
Recalls
1
Predicates
4

Its longest line of descent runs back 4 generations to K864265 (1987). 16 ancestors in all, the oldest K843963 (1985). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2014: 2 other ancestors1990: 1 other ancestor2006: 1 other ancestor2000: 1 other ancestor1999: 1 other ancestor1986: 1 other ancestor2002: 1 other ancestor1996: 1 other ancestor1994: 1 other ancestor1991: 1 other ancestor1985: 1 other ancestor2026: 1 descendant clearedK864265 · Hemodialysis Bath Concentrate Solutions for Hemodi · Dial Medical of Florida, Inc. · 1987K980659 · Dryalysate Concentrate · Advanced Renal Technologies, Inc. · 1998K160847 · Rockwell Medical CitraPure Acid Concetrate · Rockwell Medical · 2016K171750 · Citric Complete Dry Citric Acid (45X) · Dimesol USA, LLC · 2018 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 5 other ancestors3 generations back: 5 other ancestors 1 generation forward: 1 descendant K171750 · Citric Complete Dry Citric Acid (45X) · Dimesol USA, LLC · 2018 · recalledK160847 · Rockwell Medical CitraPure Acid Concetrate · Rockwell Medical · 2016K980659 · Dryalysate Concentrate · Advanced Renal Technologies, Inc. · 1998K864265 · Hemodialysis Bath Concentrate Solutions for Hemodi · Dial Medical of Florida, Inc. · 19870
  1. Root · 4 generations backK864265 Hemodialysis Bath Concentrate Solutions for HemodiDial Medical of Florida, Inc. · 1987
  2. 3 generations backK980659 Dryalysate ConcentrateAdvanced Renal Technologies, Inc. · 1998
  3. 2 generations backK160847 Rockwell Medical CitraPure Acid ConcetrateRockwell Medical · 2016
  4. 1 generation backK171750 Citric Complete Dry Citric Acid (45X)Dimesol USA, LLC · 2018 · Recalled
  5. This deviceK223431 Citric Complete Liquid Citric Acid ConcentrateNipro Renal Solutions USA, Corp. · 2023
  6. Descendant · cites it directly · 0 of its ownK260799 Nipro Dry Acid Concentrate MixerNipro Technical Solutions, Incoporated · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K260799Nipro Dry Acid Concentrate MixerNipro Technical Solutions, Incoporated · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K864265Hemodialysis Bath Concentrate Solutions for HemodiDial Medical of Florida, Inc.1987—
−3K980659Dryalysate ConcentrateAdvanced Renal Technologies, Inc.1998—
−2K160847Rockwell Medical CitraPure Acid ConcetrateRockwell Medical2016—
−1K171750Citric Complete Dry Citric Acid (45X)Dimesol USA, LLC20182
0 (this device)K223431Citric Complete Liquid Citric Acid ConcentrateNipro Renal Solutions USA, Corp.2023—
+1K260799Nipro Dry Acid Concentrate MixerNipro Technical Solutions, Incoporated2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198510
198610
199010
199110
199410
199610
199910
200010
200210
200610
201420

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K223431, 1987–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPO device

  1. #1 K233159 pureFLOW 402, pureFLOW 400, pureFLOW 406…score 14.5 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K160847Rockwell Medical CitraPure Acid Concetrate
Summary page 4
…21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code I K160847 I CitraPure@ Acid Concentrate IKPO I K130511…
Rockwell Medical2016—
*K130511Citrisol Acid Concentrate
Summary page 4
…) Product Code I K160847 I CitraPure@ Acid Concentrate IKPO I K130511 I CitriSol Acid Concentrate IKPO I K901471…
Diasol, Inc.2014—
*K901471GC-1000 Through GC-3005 Acid Concentrate
Summary page 4
…IKPO I K130511 I CitriSol Acid Concentrate IKPO I K901471 GC-1000 to GC-3005 Acid Concentrate (MedicaPureT r Liquid AI KPO I K171750 Citric Comp…
Granite Chemical Co., Inc.1990—
*K171750Citric Complete Dry Citric Acid (45X)
Summary page 4
…trate IKPO I K901471 GC-1000 to GC-3005 Acid Concentrate (MedicaPureT r Liquid AI KPO I K171750 Citric Complete TM Dry Citric Acid Concentrate IKPO I Device Descrip…
Dimesol USA, LLC20182

Also cleared against K160847: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260799Nipro Dry Acid Concentrate MixerNipro Technical Solutions, Incoporated20260

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 5, 2026Class IIZ-3136-2026Process controlHemodialysis concentrates contain high endotoxin levels

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 36 years and passes through 5 companies; a new generation was cleared every 11.2 years on median.
  • 5 of the 16 ancestors have a recall of any class.
  • Of its descendants, K260799 (Nipro Technical Solutions, Incoporated, 2026) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K160847.

How does its category compare?

All KPO devices

KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · KPO

2in 2025

2007: 22008: 22009: 12011: 12012: 22013: 12014: 22015: 12016: 12017: 32018: 22020: 52021: 12022: 22023: 32024: 32025: 22026 (partial year): 2
2007high 5 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPO

112in 2024

2017: 192 days median2020: 270 days median2023: 263 days median2024: 112 days median
2007high 270 (2020) · low 112 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPO

6in 2025

2007: 52008: 22009: 12011: 22012: 102015: 32016: 12017: 12018: 112019: 12020: 312022: 22024: 12025: 62026 (partial year): 9
2007high 31 (2020) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KPO

95in 2025

2007: 52008: 82009: 32010: 1072011: 2232012: 702013: 3,8972014: 15,9162015: 8,3402016: 2402017: 802018: 972019: 792020: 2442021: 632022: 252023: 592024: 2592025: 95
2007high 15,916 (2014) · low 3 (2009)2025

MAUDE reports naming product code KPO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—55
20082—28
20091—13
20100—0107
20111—2223
20122—1070
20131—03,897
20142—015,916
20151—38,340
20161—1240
20173192180
20182—1197
20190—179
2020527031244
20211—063
20222—225
20233263059
202431121259
20252—695
20262—9—

What is it indicated for?

For LC+100 Series: This acid concentrate is formulated for use in acute and chronic hemodialysis, and is to be used in conjunction with Nipro MedicaLyte bicarbonate concentrate, or an equivalent bicarbonate concentrate of the same composition, in a 36.83X proportioning three-stream hemodialysis machine.

For LC+200 Series: This acid concentrate is formulated for use in acute and chronic hemodialysis, and is to be used in conjunction with Nipro MedicaLyte bicarbonate concentrate, or an equivalent bicarbonate concentrate of the same composition, in a 45X proportioning three-stream hemodialysis machine.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223431: Citric Complete Liquid Citric Acid Concentrate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K223431

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026